Research – Page 2 – Policy & Medicine

PhRMA Report Shows More than 240 Immuno-Oncology Treatments in Development

FDA Drug Approvals on an Uptick

Dr. Stossel Corrects a Common Misconception

JAMA: Research Parasites Wanted

The Importance of Private Investment into Research and Development

Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation

A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drugs Entering Clinical Development is Less Than 12%

Clinical Trial Transparency Update: Eli Lilly, Bayer, Boehringer, and BMS Join Pharmaceutical Companies Sharing Patient-Level Clinical Trial Data

US Senate Special Committee on Aging: Why Research Collaborations Matter

White House PCAST: Rival Countries Gaining on US Medical Research Spending